Induction of thymidylate synthase as a 5-fluorouracil resistance mechanismGodefridus J. Peters, Herbert M. Pinedo, SJ Freemantle et al.|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|2002Cited by 430
Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanomaChiao‐En Wu, John Lunec|British Journal of Cancer|2017Cited by 63
Gefitinib (‘Iressa’, ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2J E Nutt, John Lunec|British Journal of Cancer|2004Cited by 53
ATM Dependent DUSP6 Modulation of p53 Involved in Synergistic Targeting of MAPK and p53 Pathways with Trametinib and MDM2 Inhibitors in Cutaneous MelanomaChiao‐En Wu, John Lunec|Cancers|2018Cited by 39
<i>TP53</i> mutant <i>MDM2</i>-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiationCatherine J. Drummond, John Lunec|Oncotarget|2016Cited by 21